The diflunisal trial: Update on study drug tolerance and disease progression

Amyloid

Volumn 18, Issue SUPPL. 1, 2011, Pages 196-197

  Berk, J L ^a   Dyck, P J ^b   Obici, L ^c   Zeldenrust, S R ^b   Sekijima, Y ^d   Yamashita, T ^e   Ando, Y ^e   Ikeda, S I ^d   Gorevic, P ^f   Merlini, G ^c   Kelly, J W ^g   Skinner, M ^a   Bisbee, A B ^a   Suhr, O B ^h  

^a BOSTON MEDICAL CENTER   (United States)

^b MAYO CLINIC ROCHESTER   (United States)

^c UNIVERSITY OF PAVIA   (Italy)

^d SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e KUMAMOTO UNIVERSITY   (Japan)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g SCRIPPS RESEARCH INSTITUTE   (United States)

^h UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; DIFLUNISAL; PREALBUMIN;

ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EDEMA; FAMILIAL AMYLOID POLYNEUROPATHY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; HYPERTRANSAMINASEMIA; IN VITRO STUDY; KIDNEY FAILURE; LIVER TRANSPLANTATION; MALE; MUTATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 79959948406     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2011.574354     Document Type: Article

References (6)

1. Dubrey SW, Davidoff R, Skinner M, Bergethon P, Lewis D, Falk RH. Progression of ventricular wall thickening after liver transplantation for familial amyloidosis. Transplantation 1997;64:74-80. (Pubitemid 27327203)
2. Stangou AJ, Hawkins PN, Heaton ND, Rela M, Monaghan M, Nihoyannopoulos P, O'Grady J, Pepys MB, Williams R. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis. Transplantation 1998;66:229-233. (Pubitemid 28370006)
3. Sekijima Y, Dendle MA, Kelly JW. Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis. Amyloid 2006;13:236-249. (Pubitemid 44764463)
4. Miller SR, Sekijima Y, Kelly JW. Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants. Lab Invest 2004;84:545-552. (Pubitemid 38858463)
5. Peripheral Nerve Society. Diabetic polyneuropathy in controlled clinical trials: concensus report of the Peripheral Nerve Society. Ann Neurol 1995;38:478-482.
6. Dyck PJ, Davies JL, Litchy WJ, O'Brien PC. Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology 1997;49:229-239. (Pubitemid 27328707)